Show results for
Refine by
Bioptic Equipment Supplied In Usa North Carolina
6 equipment items found
Manufactured by:MYCO Medical based inApex, NORTH CAROLINA (USA)
Product Family ; Biopsy. Sterilization ; Sterile. Size ; 21G. Length ; Choose an option. Color ; Green. ...
Manufactured by:Entero Therapeutics, Inc. based inBoca Raton, FLORIDA (USA)
A majority of individuals with CD do not recover well under a GFD. Furthermore, there is still no effective means for monitoring the intestinal health of a recovering celiac other than an invasive biopsy and even that method is prone to interpretive analysis. This problem is particularly acute in the United States where recent studies have shown that more than 50% of adult celiac patients have ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
InVisionFirst®-Lung, a ctDNA NGS liquid biopsy testing 37 genes relevant to the care of patients with advanced NSCLC. Covered for Medicare and other private insurance NSCLC patients who meet specific clinical criteria in the United States. InVisionFirst-Lung® is available world-wide for both commercial and research use. ...
by:Genova Diagnostics based inAsheville,, NORTH CAROLINA (USA)
An FDA-Cleared Gastrointestinal Test to Distinguish IBS from IBD. The Calprotectin gastrointestinal test effectively distinguishes Irritable Bowel Syndrome (IBS) from Inflammatory Bowel Disease (IBD). IBS and IBD often cause similar symptoms of abdominal pain, cramping, and chronic diarrhea, making an accurate diagnosis difficult. Calprotectin reliably differentiates IBS from IBD using a ...
Manufactured by:MYCO Medical based inApex, NORTH CAROLINA (USA)
RELI BEN Bone Marrow Biopsy Needle, Trocar point, 11G x 10cm, ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
RaDaR™ is a personalized, multi-tumor liquid biopsy assay that can track a set of up to 48 tumor-specific variants in a patient using a liquid biopsy with exceptional sensitivity. This allows RaDaR™ to detect traces of molecular residual disease (MRD) in a patient following surgery or other treatment for cancer, enabling early detection of relapse and accurate monitoring. ...